Loading chart…
PRE-MARKET
Strides Pharma Science Limited, a pharmaceutical company, engages in the development, manufacturing, and marketing of pharmaceutical products in North America, Australia, Africa, Europe, India, the rest of Asia, and internationally. The company offers generic finished dosage formulations in a range of dosages, such as tablets, hard capsules, sachets, liquids, nasal sprays, topical formulations, and controlled substances; and therapeutic products, including antivirals, antibiotics, NSAIDs, and allergy treatment.
Strides Pharma Science Limited (STAR) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The STAR share price is ₹1,002.20 (+0.26% today), with a market capitalisation of ₹92B and a price-to-earnings (P/E) ratio of 15.0. MarketRipple tracks the STAR investment thesis, the ripple-chain impact of market events on Strides Pharma Science Limited, and the Healthcare sector outlook.
Open
₹1,033.10
High
₹1,039.90
Low
₹1,000.00
Prev. Close
₹999.60
52W High
₹1,260.90
52W Low
₹768.65
Day range
₹1,000.00–₹1,039.90
52-week range
₹768.65–₹1,260.90
Volume
198K
P/E
15.0
ROE
20.3%
D/E
0.57
Margin
11.8%
Strides Pharma Science Limited (NSE: STAR) is currently trading at ₹1,002.20 (+0.26%).
Strides Pharma Science Limited's market capitalization is ₹92B.
Strides Pharma Science Limited's price-to-earnings (P/E) ratio is 15.0.
Strides Pharma Science Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
Analyst consensus on Strides Pharma Science Limited currently reads strongly positive, based on 3 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.